In an exploratory subset analysis, a CPS ≥ 1 population by 22C3 assay showed a trend for longer OS with avelumab.
also in 53,322 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.